AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Ishii, Y Miyoshi, A Watanabe, R Tsuruda, K Tsuda, M Yamaguchi-Nagamatsu, Y Yoshisue, K Tanaka, M Maji, D Ohgiya, S Oguri, K
Citation: Y. Ishii et al., Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation, MOLEC PHARM, 60(5), 2001, pp. 1040-1048

Authors: Yoshisue, K Nagayama, S Shindo, T Kawaguchi, Y
Citation: K. Yoshisue et al., Effects of 5-flourouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats, J PHARM EXP, 297(3), 2001, pp. 1166-1175

Authors: Ikeda, K Yoshisue, K Matsushima, E Nagayama, S Kobayashi, K Tyson, CA Chiba, K Kawaguchi, Y
Citation: K. Ikeda et al., Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro, CLIN CANC R, 6(11), 2000, pp. 4409-4415

Authors: Yoshisue, K Hironaga, K Yamaguchi, S Yamamoto, A Nagayama, S Kawaguchi, Y
Citation: K. Yoshisue et al., Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeatedsimultaneous administration of potassium oxonate (Oxo) in rats, CANC CHEMOT, 46(1), 2000, pp. 51-56

Authors: Yoshisue, K Yamamoto, Y Yoshida, K Saeki, M Minami, Y Esumi, Y Kawaguchi, Y
Citation: K. Yoshisue et al., Pharmacokinetics and biological fate of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate (MET-88), a novel cardioprotective agent, in rats, DRUG META D, 28(6), 2000, pp. 687-694

Authors: Yoshisue, K Masuda, H Matsushima, E Ikeda, K Nagayama, S Kawaguchi, Y
Citation: K. Yoshisue et al., Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine,and potassium oxonate) to rats, DRUG META D, 28(10), 2000, pp. 1162-1167
Risultati: 1-6 |